CNS Pharmaceuticals

-$0.0048 (-1.81%) As of 12:06 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.

CEO
John M. Climaco
Employees
5
Headquarters
Houston, Texas
Founded
2017

CNSP Key Statistics

Market cap
11.05M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.89M
High today
$0.2801
Low today
$0.2501
Open price
$0.261
Volume
537.85K
52 Week high
$1.98
52 Week low
$0.2453

CNSP Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure